1. Introduction {#sec1-ijerph-15-00294}
===============

Non-communicable diseases (NCD) are the leading cause of disability and mortality globally, being responsible for 39.5 million deaths in 2015 \[[@B1-ijerph-15-00294]\]. Diabetes mellitus (DM) is one of the four major NCDs, together with cardiovascular diseases, cancer, and chronic respiratory diseases \[[@B2-ijerph-15-00294]\]. Diabetes prevalence is rising, representing a growing challenge to public health. A total of 415 million people were estimated to be diagnosed with diabetes worldwide in 2015, and it is expected that this number will rise to 642 million by 2040 \[[@B3-ijerph-15-00294]\]. One study demonstrated worldwide prevalence trends increasing from 4.3 to 9.0% in men, and from 5.0 to 7.9% in women from 1980 to 2014, with steeper increase in low and middle-income countries \[[@B4-ijerph-15-00294]\]. Brazil ranks fourth in the world in number of individuals with diabetes \[[@B4-ijerph-15-00294]\]. The 2013 Brazilian National Health Survey (NHS) demonstrated self-reported prevalence of diabetes of 6.2% in the population aged 18 years or older, reaching 19.9% in those aged 65--74 years \[[@B5-ijerph-15-00294]\]. This prevalence is certainly underestimated given other previous Brazilian studies with laboratory confirmation, which have shown that approximately half of individuals with diabetes were unaware of the diagnosis \[[@B6-ijerph-15-00294],[@B7-ijerph-15-00294]\].

Studies have demonstrated that people with diabetes are at higher risk of hospitalization \[[@B8-ijerph-15-00294],[@B9-ijerph-15-00294],[@B10-ijerph-15-00294],[@B11-ijerph-15-00294]\] and readmission than people without diabetes \[[@B12-ijerph-15-00294],[@B13-ijerph-15-00294]\]. The diabetes economic burden is significant and is expected to increase over time. Global health expenditures related to diabetes and its complications were estimated at \$673 billion in 2015 \[[@B3-ijerph-15-00294]\]. Such costs represent a significant portion of national health expenditures, varying from 2.5 to 15% by country, depending on availability and access to healthcare services \[[@B14-ijerph-15-00294]\].

In the early 2000s, Brazil initiated a series of strategies aiming at increasing access of the population with diabetes and hypertension to healthcare services \[[@B15-ijerph-15-00294]\] and providing early diagnosis for diabetes through a national population-based screening program \[[@B16-ijerph-15-00294],[@B17-ijerph-15-00294]\]. Later, a National Strategic Plan for chronic NCD was developed and implemented \[[@B18-ijerph-15-00294]\]. This plan, in accordance to the World Bank and the International Diabetes Federation, recommends countries conduct national studies of cost of illness and economic burden of diabetes \[[@B3-ijerph-15-00294]\].

Healthcare in Brazil is provided by both public and private sectors. Public healthcare services are provided by the National Unified Health System (SUS), which offers, free of charge, universal health access covering about 75% of the population in the country \[[@B19-ijerph-15-00294]\].

Demographic, epidemiological and nutritional transition processes, urbanization and economic and social growth contribute to the greater risk of developing chronic NCD. Diabetes, stroke, myocardial infarction, hypertension, cancer and chronic respiratory diseases account for about 80% of deaths in Brazil, reaching heavily poor sections of the population and more vulnerable groups, such as the population with low schooling and income \[[@B18-ijerph-15-00294]\].

The full economic burden of diabetes in Brazil is still unknown. Hospitalization costs associated with diabetes and its complications are reported to be the most significant portion of direct medical costs. In this study, we estimated the number of hospitalizations due to DM and its complications and their economic burden in Brazil.

2. Materials and Methods {#sec2-ijerph-15-00294}
========================

2.1. Study Design, Site and Population {#sec2dot1-ijerph-15-00294}
--------------------------------------

We estimated the number of hospitalization due to DM and its complications in 2014 in Brazil, as well as its costs. We considered hospitalizations occurring in adults aged 20 years and older in all 27 states in the country, through SUS.

2.2. Ethics Approval {#sec2dot2-ijerph-15-00294}
--------------------

The Ethics Committee of Federal University of Goias in Goiania, Brazil, granted ethical approval for this investigation in October 2014 (\# 852808). Considering we used secondary publicly available data, with no personal identifiers, the Institutional Research Board (IRB) waived written individual consent.

2.3. Data Sources {#sec2dot3-ijerph-15-00294}
-----------------

### 2.3.1. Diabetes Prevalence {#sec2dot3dot1-ijerph-15-00294}

The prevalence of self-reported diabetes was obtained from the 2013 NHS \[[@B5-ijerph-15-00294]\], stratified by gender, age groups and state within the country. The original NHS database was analyzed and estimates of self-reported diabetes prevalence were generated considering a positive response of surveyed individuals to question Q030 "Has any doctor ever given a diagnosis of diabetes?", excluding individuals reporting diagnosis of gestational DM (as responded in a different question of the survey). Evidence suggests that self-report of a physician's diagnosis of diabetes is a good estimate of diagnosed diabetes \[[@B20-ijerph-15-00294]\].

As individuals with diabetes who are unaware of the disease may also be hospitalized due to diabetes or its complications, we considered the prevalence of undiagnosed diabetes for this study. To account for undiagnosed diabetes, the prevalence of self-reported diabetes was multiplied by a factor of 2, based on recent evidence from the Brazilian literature, indicating that half of the individuals with diabetes diagnosis by laboratory confirmation were unaware of their disease \[[@B7-ijerph-15-00294]\]. This strategy has been applied by other authors for the estimation of diabetes disease burden \[[@B21-ijerph-15-00294]\].

### 2.3.2. Hospitalization and Cost Data {#sec2dot3dot2-ijerph-15-00294}

All hospitalizations occurring nationwide in SUS are recorded in a National Hospitalization Information System (SIH), which includes information on hospital admissions and discharges and its costs to the SUS. We obtained raw hospitalization data from SIH-SUS, without personal identification information, which are publicly available online \[[@B22-ijerph-15-00294]\].

A standardized hospital admission form (AIH) reports the main hospitalization diagnosis. We considered two types of AIH: AIH-1 (conventional hospitalization authorization) for the estimates of diabetes hospitalizations, and AIH-5 (long-term hospitalization authorization) considered in addition to AIH-1 for economic burden estimates.

International statistical classification of diseases and related health problems, 10th revision (ICD10) codes \[[@B23-ijerph-15-00294]\] assigned for admission diagnoses of all hospitalized patients are recorded in the SIH. The databases were extracted in October/2016, and the following variables were considered: type of AIH, state of residence, sex, age group, date of admission, admission diagnosis, and cost of hospitalization. The data were extracted and analyzed in Microsoft Excel^(R)^ Office Excel (R) 2007 (12.0.4518.1014) MSO (12.0.4518.1014) spreadsheets.

### 2.3.3. Population Data {#sec2dot3dot3-ijerph-15-00294}

Considering 2014 as the base year for this cost analysis, population estimates for 2014, by age group, and gender for each state were obtained from the National Institute of Geography and Statistics. The total adult population (20 years and older) in 2014 was estimated at 137,640,060 inhabitants \[[@B24-ijerph-15-00294]\]. The age groups were divided in 5-year strata from the age of 20. Standardized hospitalization rates adjusted by gender and age group were calculated using direct standardization method.

2.4. Outcomes of Interest {#sec2dot4-ijerph-15-00294}
-------------------------

We considered hospitalizations due to diabetes and its complications. Complications included microvascular (retinopathy, nephropathy, and neuropathy), macrovascular (coronary heart disease, cerebrovascular disease, and peripheral arterial disease), respiratory and urinary tract infections, as well as selected cancers. Hospitalizations for DM in pregnancy (ICD-10 O24) were excluded.

Hospitalizations were thus categorized into two groups: (1) those in which the main diagnosis was reported as diabetes and coded as ICD10 E10 to E14; (2) those in which the main diagnosis was reported as any chronic complication of DM and related diseases, including infectious and neoplastic diseases for which DM is considered to be an important risk factor. The list of diagnosis included in this second group was adapted from the one considered by the American Diabetes Association's study of economic costs of diabetes in the US \[[@B25-ijerph-15-00294]\], and included 66 diagnosis as coded by ICD-10 three-digit codes ([Supplementary Table S1](#app1-ijerph-15-00294){ref-type="app"}).

2.5. Relative Risks {#sec2dot5-ijerph-15-00294}
-------------------

For each and all chronic complications of DM and related conditions considered, we obtained individual relative risks of hospitalization for people with diabetes compared to those without the disease. Relative risk estimates for each diagnosis were obtained through systematic literature reviews ([Supplementary Table S1](#app1-ijerph-15-00294){ref-type="app"}).

2.6. Data Analysis {#sec2dot6-ijerph-15-00294}
------------------

### 2.6.1. Burden of Hospitalizations Attributed to Diabetes and Its Complications {#sec2dot6dot1-ijerph-15-00294}

Except for hospitalizations in which the main diagnosis was reported as DM, the proportion of hospitalizations due to DM was estimated using the attributable risk methodology. This method considers that diabetic patients use healthcare services more than non-diabetics and that a portion of the care associated with such medical care can be attributed to diabetes. The risk of presenting a particular medical condition, according to the presence or absence of DM, and the proportion of the population with the disease are combined to calculate the etiological fraction.

The etiological fraction for each of the 66 conditions considered were calculated using the following formula: where RAPI is the fraction of risk attributable to the population for the medical condition "i" due to diabetes, P represents the prevalence rate of diabetes in each state by gender and age group, and iRR is the relative risk of hospitalization for people with diabetes compared to those without the disease.

A total of 702 demographic strata were generated, resulting from a combination of 2 sex categories, 13 age categories (i.e., 20--24, 25--29, 30--34, 35--39, 40--44, 45--49, 50--54, 55--59, 60--64, 65--69, 70--74, 75--79 and 80+ years), and 27 states. The number of hospitalizations for each of the conditions considered, by each of these 702 demographic strata (sex, age group, and state) was obtained.

Specific etiological fractions were then applied to the number of hospitalizations obtained for each of the 702 demographic strata, resulting in 46,332 estimates (66 ICD-10 codes multiplied by 702 demographic strata) of the proportion of hospitalizations attributable to DM.

Results were further grouped in four age groups (20--44, 45--64, 65--74 and 75+ years old), and are reported by sex, age group and main diagnosis. Diagnosis groups considered for reporting results are DM, cardiovascular disease, kidney disease, eye disease, neurological disease, infectious disease, and neoplasms.

Proportion of hospitalization and population hospitalization rates (per 10,000 population aged 20 years and older) are reported, comparing overall hospitalizations and those due to diabetes.

### 2.6.2. Direct Medical Costs Attributed to Diabetes and Its Complications {#sec2dot6dot2-ijerph-15-00294}

Economic burden analysis considered the SUS perspective as payer. A top-down costing methodology was used considering on the combination of prevalence and relative risks \[[@B26-ijerph-15-00294]\]. This methodology allocates to diabetes a portion of the total expenditures of hospitalizations (for several conditions) that could be due to the diabetes, based on the estimate of the proportion of total services consumed by individuals with the disease \[[@B27-ijerph-15-00294],[@B28-ijerph-15-00294]\] as described above.

Hospitalization charges are based on Diagnostic Related Groups (DRG), with addition of values resulting from on intensive care unit (ICU) stay, certain special medications, prostheses and other selected materials. In addition to these direct medical costs, which include hospital stay, staff, diagnostic and therapeutic procedures, materials and drugs, non-medical costs for hospital stay of a parent or caregiver accompanying the hospitalized individual is also included. Reimbursed values by cost items are standardized nationwide based on SUS own price list \[[@B29-ijerph-15-00294]\].

Monetary values were obtained in Brazilian reais (R\$) and then converted to international dollars (Int\$) considering the purchasing power parity (PPP) (conversion factor 1.748) \[[@B30-ijerph-15-00294]\].

Total hospitalization costs and average cost per hospitalization, by diagnostic groups, and by specific hospitalization cause are presented, comparing all hospitalizations and those attributed to diabetes. Costs are further presented stratified by gender and age group.

3. Results {#sec3-ijerph-15-00294}
==========

We considered the national prevalence of undiagnosed diabetes as 12.4%, varying by age group and state ([Supplementary Table S2](#app1-ijerph-15-00294){ref-type="app"}). As such, we estimated that 17,320,339 adult individuals in the country would have diabetes.

A total of 11.3 million hospitalizations were registered in 2014 in the SIH/SUS, of which 8,629,004 million (76.2%) were adults (20 or more years). Of these adult hospitalizations, 284,675 received an authorization for prolonged stay (AIH-5).

In 2014, an estimated 313,273 hospitalizations due to diabetes occurred in Brazil, corresponding to 3.6% of total hospitalizations and representing a hospitalization rate of 22.8/10,000 adults. Excluding hospitalizations for pregnancy, childbirth and the puerperium, hospitalizations attributable to diabetes represent 4.6% of total adult hospitalization in Brazil in 2014.

Among these, DM per se (ICD-10 codes E10--E14) accounted for 41.9% of hospitalizations, followed by cardiovascular diseases attributable to diabetes (26.5%) ([Table 1](#ijerph-15-00294-t001){ref-type="table"}). The population hospitalization rates increased from 3.5 and 3.8/10,000 adults for men and women, respectively, aged 20--44 years to 146.0 and 133.3 for the age group of 75 and over. Women were hospitalized more than men when considering both absolute number and crude hospitalization rate. However, when considering age-standardized rates, these are higher for men (23.9/10,000 population) when compared to women (21.9/10,000 population). While the average cost of a hospitalization of an adult individual was Int\$709 in 2014, the average cost of a hospitalization due to diabetes and related diseases was 19% higher, reaching Int\$845. Among the hospitalizations due to diabetes, hospitalizations due to kidney (Int\$1602) and cardiovascular (Int\$1529) diseases were the ones with higher average cost, and hospitalizations due to diabetes had the lower average cost (Int\$364). Average hospitalization cost was significantly higher in men in all age groups and for all diagnosis groups, except for selected neoplasms, probably because of breast cancer costs included in this group ([Table 2](#ijerph-15-00294-t002){ref-type="table"}).

Total costs for adult hospitalization in the SUS in 2014 were approximately Int\$6.1 billion. Admissions due to diabetes and related conditions reached Int\$264.9 million, representing 4.3% of total hospitalization costs. After excluding hospitalizations for pregnancy, childbirth and the puerperium, this proportion increased to 4.8%. Diabetes mellitus per se accounted for only 18.1% of total costs attributable to hospitalization due to diabetes and related conditions, with cardiovascular diseases attributable to diabetes (47.9%) accounting for the higher proportion of overall costs. Total hospitalization costs were significantly higher in men from 20--74 years. The reverse was observed in the age group of 75 years and older ([Table 3](#ijerph-15-00294-t003){ref-type="table"}).

Among the hospitalizations with the main diagnosis reported as DM, the number of hospitalizations (52.5%), and total costs (46.2%) related to unspecified DM ICD-10 code E14) were the most observed, despite presenting the lower average hospitalization cost. The second most relevant cause of hospitalization in this group was insulin-dependent hospitalizations (ICD-10 E10), with the higher average hospitalization cost ([Table 4](#ijerph-15-00294-t004){ref-type="table"}).

Cardiovascular diseases due to diabetes accounted for 13.1% (n = 82,958) of admissions and 14.3% (Int\$126,849,817) of costs of all hospitalizations for cardiovascular diseases in SUS. In hospitalizations due to diabetes, average hospitalization costs due to cardiovascular disease were 10.4% higher than non-diabetes hospitalizations. Among all hospitalizations due to cerebral infarction (ICD-10 code I63) and transient ischemic stroke and related syndromes (ICD-10 code G45), 25% of hospitalizations and costs could be attributed to diabetes ([Table 5](#ijerph-15-00294-t005){ref-type="table"}).

Microvascular diseases due to diabetes (kidney, eye and neurologic diseases) accounted for a greater share of total hospitalizations (29.1%) and associated costs (24.5%). Of worth noting is the high number of hospitalization and overall costs with diabetes hospitalization due to renal diseases, in particular due to chronic kidney disease (ICD-10 code N18) ([Table 6](#ijerph-15-00294-t006){ref-type="table"}).

Hospitalizations for respiratory and urinary infections, for which diabetes was considered a risk factor, represent a small percentage (5.3%) when compared to the cardiovascular (13.1%) and microvascular (29.1%) groups in relation to total SUS and accounted for 6.5% of hospitalizations due to DM. Even so, this percentage was reached due to the large participation of respiratory infections (96.5%) in this group, with emphasis on pneumonia per unspecified organism (ICD-10 J18) (69.9%) ([Table 7](#ijerph-15-00294-t007){ref-type="table"}).

Hospitalizations for neoplastic diseases have a small participation (7.3%) of total hospitalizations in comparison with other groups and represent 2.7% of hospitalizations due to DM. Breast cancer (4.0%) and colorectal cancer (5.8%) admissions were among those with the lowest values, while cancers of endometrium (20.0%), pancreas (18.6%) and liver and intrahepatic bile ducts (22.6%) were among those with the highest values ([Table 8](#ijerph-15-00294-t008){ref-type="table"}).

4. Discussion {#sec4-ijerph-15-00294}
=============

Brazil is one of the most populated countries in the world, with an estimated population of 137.6 million adults in 2014 \[[@B31-ijerph-15-00294]\]. Based on recent prevalence estimates, we have estimated that 17.3 million individuals aged 20 years and older had diabetes in Brazil ([Supplementary Table S2](#app1-ijerph-15-00294){ref-type="app"}). Despite increasing trends in diabetes prevalence in the country, mortality due to diabetes declined 1.7% per year (from 40.6/100 thousand population to 33.7/100 thousand population) from 2000 to 2011, probably as a result of better access to healthcare, thus reducing mortality due to acute events \[[@B32-ijerph-15-00294]\]. However, when diabetes was analyzed as an associated cause of death due to other causes, there was an increase of 8% between 2000 and 2007 \[[@B33-ijerph-15-00294]\], most likely representing deaths due to chronic diabetes complications and related conditions.

Hospitalizations represent an important part of the consumption of health resources in different health systems and countries around the world and patients with type 2 diabetes had higher rates of hospitalization than the general population \[[@B34-ijerph-15-00294]\]. In the United States in 2012, diabetes hospitalization costs were the most significant cost component (43%) of direct medical costs (\$176 billion) associated with diabetes, which added to \$245 billion when considering both direct and indirect costs \[[@B25-ijerph-15-00294]\].

The estimated costs of hospitalizations due to diabetes and related conditions estimated in this study (Int\$264.9 million) represent 4.6% of all hospitalizations and 0.45% of all expenditures for actions and public services of health provided by the Ministry of Health in 2014 (Int\$58.3 billion) \[[@B35-ijerph-15-00294]\]. In this same year, total health expenditures in Brazil were 8% of its Gross Domestic Product of which 46% was associated with public health expenditures (Int\$606 per capita) \[[@B36-ijerph-15-00294]\]. This spending is equivalent to Int\$1.92 per adult by the federal government only with hospitalizations for DM and its complications. The average value of an adult hospitalization due to diabetes was 19% higher than a hospitalization without diabetes, and hospitalizations due to kidney and cardiovascular diseases were the ones with higher average cost.

Most countries in Latin America have adopted public health systems with universal coverage in the last few decades. Nonetheless, disparities in per capita government health expenditure can be observed in the region \[[@B37-ijerph-15-00294]\] and a wide difference can be identified between countries that share historic similarities, with Venezuela with the lowest (Int\$270.88), and Cuba (Int\$2366.06) the highest per capita government health expenditure \[[@B36-ijerph-15-00294]\]. When contrasting with high-income developed countries in other regions, disparities are more pronounced, with United States (Int\$4541.17), United Kingdom (Int\$2807.62), and Japan (Int\$3115.08) among the highest per capita expenditures \[[@B36-ijerph-15-00294]\].

Our results demonstrated that the population aged 65 years and older used a much larger portion of hospital resources, both in number of hospitalization and costs, similar to results demonstrated in the United States in 2012 \[[@B25-ijerph-15-00294]\]. Cardiovascular complications attributable to diabetes also represented the largest share of all hospitalizations, both in number of hospitalizations and costs.

Although when considering crude rates, women were more likely to be hospitalized than men, when adjusting for age taking into consideration the different age structure between men and women, men are more likely to be hospitalized than women. Although men had relatively higher hospitalization costs than women from age group 20--74 years, except for the ≥75 years age group, this may be due to the relatively longer life expectancy in women, compared with men \[[@B38-ijerph-15-00294]\]. Hospitalizations reported as having diabetes as the main diagnosis were the most frequent (41.9%), although with lower costs. They currently represent a small proportion of all hospitalization expenses for the Brazilian National Health System, but are expected to increase considerably as the population ages. Moreover, hospitalization costs related to diabetes, but not captured by a first listed diabetes diagnosis, must be integrated with these costs to give a more comprehensive picture of the overall disease burden attributable to diabetes.

The total number of hospitalizations due to DM-related conditions was 2.4 times that of hospitalizations for first-listed DM; however, spending was almost 5.5 times higher. Microvascular diseases due to diabetes (kidney, eye and neurologic diseases) accounted for a greater share of total hospitalizations (29.1%) and associated costs (24.5%), part of which could be prevented with a better metabolic control. These results were in accordance with others that show hospitalizations for diabetes complications had a higher average cost than those for diabetes itself \[[@B25-ijerph-15-00294],[@B39-ijerph-15-00294],[@B40-ijerph-15-00294]\].

The hospitalization costs due to infectious diseases and selected neoplasms in adults with DM were 4.8% and 3.9%, respectively, of the total hospitalizations due to DM. Although it represents a small percentage compared with vascular diseases, currently, this was the first Brazilian study to consider DM as an important contributor to such hospitalizations and costs.

Comparisons with Brazilian studies for 1999--2001 \[[@B41-ijerph-15-00294]\] and 2008--2010 \[[@B42-ijerph-15-00294]\], that used the same attributable risk methodology to estimate hospitalizations for DM in the Brazilian public network, should be performed with caution. In both previous studies, the results encompassed all age groups while in the current, only adults. In addition, in the two previous studies, hospitalizations were also estimated for the general medical conditions group, i.e., all other ICD-10 diseases that are not attributed to diabetes or its complications but for which individuals with DM were hospitalized more frequently. In contrast, in the current study, some of these conditions, such as certain neoplasms and lower respiratory and urinary tract infections, were computed as diabetes complications. It is also recognizable that the more recent literature has brought lower relative risks from international studies for the calculation of etiological fractions, although it was partially offset by the double of self-reported prevalence.

Our study has several limitations which are worth noting. The source of the data (SIH/SUS) was initially developed for administrative-financial functions for the purpose of collection and may not be free of coding errors, intentional or not. This is reflected by the high number of individuals hospitalized for whom the main diagnosis reported as DM was "unspecified DM---E14" (n = 68,987), and "insulin-dependent hospitalizations---E10" (n = 38,883), significantly higher than those reported as "non-insulin dependent diabetes---E11" (12,707). We believe that most of these cases reported as E14 are indeed individuals with type 2 DM. Also, many of the cases reported as E10 may be individuals with type 2 diabetes using insulin.

In addition, the SUS covers 75% of the population in Brazil, which means about one quarter of population with diabetes was not included in the data analysis, and thus our estimates may be underestimated. Moreover, the diabetes hospitalization rates may be different among those not covered by SUS. As SIH data do not incorporate critical variables with explanatory potential, such as body mass index, race, schooling, severity of the clinical condition at the time of hospitalization, degree of use of the services, readmissions and other, we are not able to identify the role of these possible factors in diabetes hospitalizations.

Another limitation is we considered only the adult population, as the focus of the study was on type 2 DM, which is more amenable to prevention strategies. As such, although hospitalizations due to type 1 DM may have been inadvertently included in our estimation, on the other hand, we might have underestimated cases of type 2 DM in those younger than 20 years of age.

Finally, as the more recent prevalence estimate available was that for self-reported diabetes \[[@B5-ijerph-15-00294]\], to account for undiagnosed diabetes, and as done by other authors \[[@B21-ijerph-15-00294]\], we applied a factor of 2, considering high quality recent evidence from Brazil \[[@B7-ijerph-15-00294]\]. The resulting diabetes prevalence of 12.4% considered in our analyses is consistent with sub-national studies in Brazil which a decade ago showed 2 digit prevalence figures in selected regions of the country, being 12.1% in the city of Ribeirão Preto \[[@B43-ijerph-15-00294]\], 12.4% in Porto Alegre \[[@B44-ijerph-15-00294]\], and 13.5% in São Carlos \[[@B45-ijerph-15-00294]\]. It is also consistent with prevalence estimates considered for global disease burden estimate studies \[[@B21-ijerph-15-00294]\].

5. Conclusions {#sec5-ijerph-15-00294}
==============

This study presented a detailed overview of the hospitalizations attributable to DM in the Brazilian public network. It is a study that deals with the epidemiological and economic aspects of the public expenses with a disease. They portrayed an "epidemiological iceberg" present in developing societies such as Brazil. By increasing the incidence and severity of other diseases, diabetes increases the chances of hospitalization of patients and the use of more aggressive therapies. We believe that improving the quality of life of these patients depends, among other measures, on the expansion of preventive activities in order to reduce the need for hospitalization, minimize complications and reduce the severity of other more general medical conditions. Our estimate is part of the monitoring and analysis of the health situation for the necessary interventions. Understanding the costs of diabetes and its major complications is crucial to raise awareness and allow the assessment of strategies to reduce its prevalence and their impact.

This study was funded by the Brazilian Ministry of Health through the National Health Fund (Process \# 25000.105417/2014-01), as part of a larger study to estimate the costs of type 2 diabetes mellitus in Brazil. The Brazilian Institute of Health Technology (IATS)/National Council for Scientific and Technological Development (CNPq) supported the open access publication costs.

The following are available online at <http://www.mdpi.com/1660-4601/15/2/294/s1>, Table S1: DM and related conditions and relative risks, Table S2: State level prevalence and hospitalization cost due to diabetes and related conditions, adults (20+ years), SUS, Brazil, 2014.
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ijerph-15-00294-t001_Table 1

###### 

Number and rates of hospitalization due to diabetes and related conditions, by age-group and sex, Unified Health System (SUS), Brazil, 2014.

                                        Age Groups (Years)                                                                                      
  ------------------------------------- -------------------- -------- -------- -------- -------- -------- -------- -------- --------- --------- ---------
  Diabetes Mellitus                     8898                 10,243   25,991   27,141   14,014   17,689   10,465   16,931   59,368    72,004    131,372
  Attributed to diabetes                                                                                                                        
  Cardiovascular Disease \*             1588                 1683     14,527   12,046   14,482   13,536   10,683   14,412   41,281    41,678    82,958
  Kidney Disease                        1017                 1170     4066     3385     3750     2844     3475     2852     12,308    10,251    22,559
  Eye Disease                           315                  216      2417     2885     3400     5326     2333     3922     8465      12,349    20,814
  Neurological Disease \*\*             1668                 976      6200     4561     4165     3268     2820     3050     14,853    11,855    26,708
  Infectious Disease \*\*\*             564                  685      1847     1866     2547     2614     4405     5846     9362      11,011    20,373
  Neoplasms \*\*\*\*                    104                  439      1105     2332     1016     1865     542      1085     2767      5721      8488
  Total \*\*\*\*\*                      14,154               15,412   56,154   54,217   43,374   47,142   34,723   48,098   148,404   164,869   313,273
  Crude Rate/10,000 population          3.5                  3.8      28.4     25.4     101.6    90.1     146.0    133.3    22.2      23.3      22.8
  Age adjusted Rate/10,000 population                                                                                       23.9      21.9      

\* Coronary heart disease and cerebrovascular disease; \*\* Diagnoses related to diabetic neuropathy; \*\*\* Urinary and respiratory infections; \*\*\*\* Breast, endometrial, pancreas, colorectal, hepatocarcinoma, cholangiocarcinoma. \*\*\*\*\* Numbers do not necessarily sum to totals because of rounding.

ijerph-15-00294-t002_Table 2

###### 

Average hospitalization cost (Int\$) due to diabetes and related conditions by age-group and sex, SUS, Brazil, 2014.

                              Age Groups (Years)                                                                  
  --------------------------- -------------------- ------ ------ ------ ------ ------ ------ ------ ------ ------ ------
  Diabetes Mellitus           551                  516    355    319    360    321    340    324    383    349    364
  Attributed to diabetes                                                                                          
  Cardiovascular Disease \*   1245                 916    1960   1469   1908   1478   1364   1036   1760   1300   1529
  Kidney Disease              3393                 2543   2292   1909   1400   1189   823    853    1696   1488   1602
  Eye Disease                 1324                 1206   917    750    627    525    497    455    700    567    621
  Neurological Disease \*\*   545                  486    653    595    745    691    807    769    696    657    679
  Infectious Disease \*\*\*   578                  435    669    607    681    635    615    620    642    610    624
  Neoplasms \*\*\*\*          1054                 1146   1135   1214   1250   1230   1233   1214   1194   1214   1207
  Total \*\*\*\*\*            855                  736    994    768    1065   808    801    664    956    746    845

\* Coronary heart disease and cerebrovascular disease; \*\* Diagnoses related to diabetic neuropathy; \*\*\* Urinary and respiratory infections; \*\*\*\* Breast, endometrial, pancreas, colorectal, hepatocarcinoma, cholangiocarcinoma. \*\*\*\*\* Numbers do not necessarily sum to totals because of rounding.

ijerph-15-00294-t003_Table 3

###### 

Total hospitalization cost (in 000 Int\$) due to diabetes and related conditions by age group and sex, SUS, Brazil, 2014.

                              Age Groups (Years)                                                                                                        
  --------------------------- -------------------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ----------- ----------- -----------
  Diabetes Mellitus           4906.8               5287.7     9231.7     8650.5     5050.5     5684.6     3559.1     5489.5     22,747.9    25,112.4    47,860.3
  Attributed to diabetes                                                                                                                                
  Cardiovascular Disease \*   1977.4               1540.9     28,480.1   17,698.6   27,636.5   20,006.1   14,573.2   14,934.9   72,667.3    54,180.5    126,847.8
  Kidney Disease              3449.4               2975.7     9320.8     6461.9     5250.6     3380.8     2859.6     2432.4     20,880.3    15,250.9    36,131.2
  Eye Disease                 416.9                260.7      2217.3     2162.8     2133.3     2798.2     1159.3     1782.6     5926.8      7004.3      12,931.1
  Neurological Disease \*\*   909.6                475.0      4049.4     2713.4     3101.1     2258.1     2276.1     2346.6     10,336.2    7793.1      18,129.3
  Infectious Disease \*\*\*   325.6                298.0      1236.4     1132.6     1734.8     1660.2     2709.9     3624.1     6006.7      6714.9      12,721.6
  Neoplasms \*\*\*\*          109.7                502.4      1254.6     2831.1     1270.1     2292.8     668.2      1317.9     3302.4      6944.2      10,246.6
  Total \*\*\*\*\*            12,095.4             11,340.6   55,790.3   41,650.9   46,176.9   38,080.8   27,805.4   31,928     141,867.8   123,000.3   264,867.9

\* Coronary heart disease and cerebrovascular disease; \*\* Diagnoses related to diabetic neuropathy; \*\*\* Urinary and respiratory infections; \*\*\*\* Breast, endometrial, pancreas, colorectal, hepatocarcinoma, cholangiocarcinoma. \*\*\*\*\* Numbers do not necessarily sum to totals because of rounding.
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###### 

Number, average and total hospitalization cost due to diabetes (E10--E14), adults (20+ years), SUS, Brazil, 2014.

  Diabetes Codes                                Number    Average Hospitalization Cost   Total Hospitalization Cost
  --------------------------------------------- --------- ------------------------------ ----------------------------
  E10 Insulin-dependent diabetes mellitus       38,883    452.62                         17,599.3
  E11 Non-insulin-dependent diabetes mellitus   12,707    340.82                         4330.7
  E12 Malnutrition-related diabetes mellitus    1454      384.83                         559.5
  E13 Other specified diabetes mellitus         9341      349.68                         3266.4
  E14 Unspecified diabetes mellitus             68,987    320.41                         22,104.3
  Total Diabetes (E10--E14) \*                  131,372   364.31                         47,860.2

\* Numbers do not necessarily sum to totals because of rounding.
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###### 

Number, average and total hospitalization cost due to cardiovascular disease, overall and related to diabetes, adults (20+ years), SUS, Brazil, 2014.

                                                                                             Overall Hospitalization   Hospitalization Due to Diabetes                                  
  ------------------------------------------------------------------------------------------ ------------------------- --------------------------------- ----------- -------- --------- -----------
  I20 Angina pectoris                                                                        123,897                   2265.29                           280,662.5   21,202   2318.49   49,156.1
  I21 Acute myocardial infarction                                                            91,951                    2025.70                           186,265.3   13,784   2036.35   28,070.1
  I23 Certain current complications following acute myocardial infarction                    937                       2069.76                           1939.4      137      2293.55   315.1
  I24 Other acute ischemic heart diseases                                                    19,283                    2878.38                           55,503.8    3005     3009.33   9041.7
  I22 Subsequent myocardial infarction                                                       2248                      1669.43                           3752.9      340      1720.45   584.4
  I25 Chronic ischemic heart disease                                                         14,856                    4065.16                           60,392.1    2712     4065.62   11,027.9
  I10 Essential (primary) hypertension                                                       74,141                    202.77                            15,033.7    10,075   228.94    2306.6
  I11 Hypertensive heart disease                                                             9704                      244.19                            2369.6      736      271.00    199.5
  I12 Hypertensive renal disease                                                             1159                      1736.11                           2012.2      254      1277.07   324.6
  I50 Heart failure                                                                          220,476                   790.71                            174,333.6   19,892   776.83    15,453
  I60 Subarachnoid haemorrhage                                                               9406                      3339.63                           31,412.6    259      3129.97   810.4
  I61 Intracerebral haemorrhage                                                              13,031                    1555.16                           20,265.3    404      1507.63   608.6
  I62 Other non-traumatic intracranial haemorrhage                                           3736                      2118.63                           7915.2      113      2033.32   229.3
  I63 Cerebral infarction                                                                    15,523                    909.46                            14,117.5    3787     920.99    3487.8
  I65 Occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction   2775                      2782.18                           7720.5      115      2755.04   315.5
  I66 Occlusion and stenosis of cerebral arteries, not resulting in cerebral infarction      1255                      840.22                            1054.5      45       784.87    35.2
  I67.2 Cerebral atherosclerosis                                                             49                        1303.74                           63.9        10       1313.46   12.9
  I69 Sequelae of cerebrovascular disease                                                    7642                      1577.12                           12,052.4    1096     1837.99   2014.7
  G45 Transient cerebral ischemic attacks and related syndromes                              20,969                    573.59                            12,027.6    4993     571.77    2854.6
  Total cardiovascular disease \*                                                            633,038                   1404.17                           888,894.5   82,958   1529.05   126,847.9

\* Numbers do not necessarily sum to totals because of rounding.
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###### 

Number, average and total hospitalization cost due to renal, ophthalmological and neurological diseases, overall and related to diabetes microvascular complications, adults (20+ years), SUS, Brazil, 2014.

                                                                              Overall Hospitalization   Hospitalization Due to Diabetes                                  
  --------------------------------------------------------------------------- ------------------------- --------------------------------- ----------- -------- --------- ----------
  Renal diseases                                                                                                                                                         
  N04 Nephrotic syndrome                                                      2156                      362.89                            782.4       313      379.81    119.1
  R77.0 Abnormality of albumin                                                \-                        \-                                \-          \-       \-        \-
  R80 Isolated proteinuria                                                    2                         72.08                             144         0.2      74.58     15
  N17 Acute renal failure                                                     21,960                    1058.82                           23,251.7    5555     1030.23   5722.6
  N18 Chronic kidney disease                                                  71,720                    2243.99                           160,939.2   16,678   1816.06   30,288.3
  N19 Unspecified kidney failure                                              48                        162.37                            7.8         13       102.91    1.3
  *Sub-total renal disease*                                                   95,886                    1929.18                           184,981.3   22,559   1601.63   36,131.2
  Eye diseases                                                                                                                                                           
  H25 Senile cataract                                                         37,852                    343.59                            13,005.7    15,947   342.19    5456.9
  H28 Cataract and other disorders of lens in diseases classified elsewhere   46                        289.47                            13.3        17       277.92    4.6
  H33 Retinal detachments and breaks                                          15,858                    1560.10                           24,740.1    4773     1560.32   7447.01
  H34 Retinal vascular occlusions                                             8                         55.06                             440         3        52.36     143
  H35.0 Background retinopathy and retinal vascular changes                   5                         105.61                            528         2        41.76     80
  H35.2 Other proliferative retinopathy                                       \-                        \-                                \-          \-       \-        \-
  H36.0 Retinal disorders in diseases classified elsewhere                    159                       128.45                            20.4        53       129.84    6.9
  H42 Glaucoma in diseases classified elsewhere                               21                        305.80                            6.4         6        313.53    1.8
  H54 Visual impairment including blindness (binocular or monocular)          56                        837.97                            46.9        14       968.52    13.5
  *Sub-total ophthalmological disease*                                        54,005                    700.56                            37,833.9    20,814   621.26    12,931.1
  Neurological diseases                                                                                                                                                  
  G90 Disorders of autonomic nervous system                                   205                       1347.22                           276.9       23       1821.26   41.5
  G56 Mononeuropathies of upper limb                                          13,303                    251.55                            3346.3      1678     250.63    420.5
  G57 Mononeuropathies of lower limb                                          223                       522.86                            116.6       24       585.04    14,3
  G59.0 Diabetic mononeuropathy                                               5                         163.55                            818         1        174.99    169
  G63 Polyneuropathy in diseases classified elsewhere                         2407                      355.05                            854.6       334      347.54    116.1
  G52 Disorders of other cranial nerves                                       239                       1319.55                           315.4       30       1253.71   37.4
  L97 Ulcer of lower limb, not elsewhere classified                           30,145                    527.87                            15,912.6    4673     534.64    2498.4
  S88 Traumatic amputation of lower leg                                       1031                      1040.48                           1072.7      638      1023.73   653.1
  S98 Traumatic amputation of ankle and foot                                  2586                      397.03                            1026.7      984      455.94    448.8
  R02 Gangrene, not elsewhere classified                                      25,564                    678.54                            17,346.1    13,107   730.75    9577.8
  M86 Osteomyelitis                                                           13,209                    572.71                            7564.9      4480     625.41    2801.8
  M87 Osteonecrosis                                                           1785                      1859.59                           3319.4      736      2064.04   1520.01
  *Sub-total neurological disease*                                            90,702                    563.96                            51,152.3    26,708   678.80    18,129.3
  Total renal, ophthalmological and neurological disease \*                   240,593                   1138.72                           273,967.4   70,081   958.77    67,191.6

\* Numbers do not necessarily sum to totals because of rounding.
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###### 

Number, average and total hospitalization cost due to respiratory and urinary infectious diseases, overall and related to diabetes, adults (20+ years), SUS, Brazil 2014.

                                                      Overall Hospitalization   Hospitalization Due to Diabetes                                  
  --------------------------------------------------- ------------------------- --------------------------------- ----------- -------- --------- ----------
  Respiratory infections                                                                                                                         
  J12 Viral pneumonia, not elsewhere classified       22,596                    499.97                            11,297.3    1075     530.04    569.9
  J13 Pneumonia due to Streptococcus pneumoniae       1315                      508.58                            668.8       76       520.54    39.6
  J14 Pneumonia due to Haemophilus influenzae         288                       435.05                            125.3       13       422.61    5.7
  J15 Bacterial pneumonia, not elsewhere classified   79,130                    679.63                            53,778.8    4250     712.67    3028.8
  J18 Pneumonia, organism unspecified                 254,891                   611.59                            155,889.9   14,246   624.25    8893.1
  *Sub-total lower respiratory tract infections*      358,220                   619.06                            221,760.1   19,661   637.67    12,537.1
  Urinary tract infections                                                                                                                       
  N10 Acute tubulo-interstitial nephritis             20,247                    200.30                            4055.5      472      232.49    109.7
  N15.1 Renal and perinephric abscess                 699                       1040.41                           727.2       17       1071.13   18.1
  N30.0 Acute cystitis                                6873                      217.55                            1495.2      180      257.28    46.3
  N30.8 Other cystitis                                1718                      215.64                            370.5       44       237.58    10.4
  *Sub-total urinary tract infections*                29,537                    225.09                            6648.5      712      258.93    184.5
  Total infectious disease \*                         387,757                   589.05                            228,408.6   20,373   624.43    12,721.6

\* Numbers do not necessarily sum to totals because of rounding.
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###### 

Number, average and total hospitalization cost due to neoplasms, overall and related to diabetes, adults (20+ years), SUS, Brazil, 2014.

                                                                                       Overall Hospitalization   Hospitalization Due to Diabetes                                
  ------------------------------------------------------------------------------------ ------------------------- --------------------------------- ----------- ------ --------- ----------
  Breast                                                                                                                                                                        
  C50 Malignant neoplasm of breast                                                     55,580                    1160.08                           64,477.2    2200   1146.46   2522.2
  D05.9 Carcinoma in situ of breast, unspecified                                       1192                      989.73                            1179.8      44     999.72    43.5
  *Sub-total breast cancer*                                                            56,772                    1156.50                           65,656.9    2244   1143.61   2565.7
  Endometrium                                                                                                                                                                   
  C54.1 Malignant neoplasm of corpus uteri                                             3539                      1409.76                           4989.1      716    1429.85   1023.4
  D07.0 Carcinoma in situ of other and unspecified genital organs                      202                       151.49                            30.6        31     158.36    4.9
  *Sub-total endometrium cancer*                                                       3741                      1341.82                           5019.7      747    1376.34   1028.4
  Pancreas                                                                                                                                                                      
  C25 Malignant neoplasm of pancreas                                                   7867                      1173.41                           9231.2      1464   1128.19   1652.2
  *Sub-total pancreas cancer*                                                          7867                      1173.41                           9231.2      1464   1128.19   1652.2
  Liver and intrahepatic bile ducts                                                                                                                                             
  C22.1 Intrahepatic bile duct carcinoma                                               807                       1082.93                           873.9       151    1069.35   161.9
  C22.0 Liver cell carcinoma                                                           2517                      1306.91                           3289.5      589    1282.92   755.4
  C22.7 Other specified carcinomas of liver                                            882                       1545.40                           1363.0      197    1455.41   287.1
  C22.9 Malignant neoplasm of liver and intrahepatic bile ducts---liver, unspecified   3158                      547.64                            1729.4      726    527.42    383.2
  *Sub-total liver and cholangiocarcinoma cancer*                                      7364                      985.32                            7255.9      1664   954.10    1587.6
  Colorectal                                                                                                                                                                    
  C18 Malignant neoplasm of colon                                                      37,627                    1238.60                           46,604.8    2187   1329.29   2907.7
  C19 Malignant neoplasm of recto sigmoid junction                                     2946                      2727.89                           8036.4      181    2787.70   505.01
  *Sub-total colorectal cancer*                                                        40,573                    1346.74                           54,641.2    2369   1440.83   3412.7
  Total neoplasms disease \*                                                           116,317                   1219.13                           141,804.9   8488   1207.23   10,246.6

\* Numbers do not necessarily sum to totals because of rounding.
